Uracil-DNA glycosylase releases free uracil from DNA and initiates base excision repair for removal of this potentially mutagenic DNA lesion. Using the yeast twohybrid system, human uracil-DNA glycosylase encoded by the UNG gene (UNG) was found to interact with the C-terminal part of the 34-kDa subunit of replication protein A (RPA2). No interaction with RPA4 (a homolog of RPA2), RPA1, or RPA3 was observed. A sandwich enzyme-linked immunosorbent assay with trimeric RPA and the two-hybrid system both demonstrated that the interaction depends on a region in UNG localized between amino acids 28 and 79 in the open reading frame. In this part of UNG a 23-amino acid sequence has a significant homology to the RPA2-binding region of XPA, a protein involved in damage recognition in nucleotide excision repair. Trimeric RPA did not enhance the activity of UNG in vitro on single-or double-stranded DNA. A part of the N-terminal region of UNG corresponding in size to the complete presequence was efficiently removed by proteinase K, leaving the proteinase K-resistant compact catalytic domain intact and fully active. These results indicate that the N-terminal part constitutes a separate structural domain required for RPA binding and suggest a possible function for RPA in base excision repair.
dinic endonuclease, a deoxyribophosphodiesterase activity (which may be contributed by DNA polymerase ␤), DNA polymerase ␤, and a DNA ligase (2) . In analogy to the complexity of the nucleotide excision repair pathway, base excision repair is likely to be more complex in vivo. This is in fact supported by the finding of an alternative, short patch pathway, requiring proliferating cell nuclear antigen and DNA polymerase ␦ (3, 4) . A catalytically fully active form of human UDG has been expressed in Escherichia coli (5) and structure-function relationships determined by site-directed mutagenesis and x-ray crystallography (6) . These studies identified this form of human UDG as a one domain structure with a positively charged DNA-binding groove. UDGs are relatively small monomeric enzymes that, at least in vitro, do not require cofactors. However, UDG is preferentially associated with replicating SV40 minichromosomes, indicating a possible interaction with components of the replication machinery (7) . The gene encoding the major human UDG, UNG, is transcribed predominantly late in the G 1 -phase, resulting in a 2-3-fold increase in UDG activity early in the S-phase (8) . The cell cycle regulation is consistent with the presence of several putative regulatory elements detected in the UNG gene (9) , including a putative element for binding of replication protein A (RPA) (10) reported previously in DNA repair genes in yeast (11) . RPA is a trimeric protein required for initiation of DNA replication (12, 13) , in the initial steps of nucleotide excision repair in physical interaction with XPA (14) , as well as in recombination repair (15) . RPA interacts with XPA both via the p70 subunit (RPA1) and the p34 subunit (RPA2) (16) . RPA from non-mammalian species substitutes poorly for human RPA during initiation of SV40 DNA replication (17, 18) , and C-terminally deleted human RPA2 is only marginally active (19) . RPA2 is phosphorylated within the replication initiation complex early in the S-phase (20) or following DNA damage caused by ultraviolet light (21) or ionizing radiation (22) , but the role of phosphorylated RPA2 remains unclear. A human homolog of RPA2, called RPA4, has been identified (23) , but its function is not known. The tumor suppressor p53 physically interacts with and inhibits the function of RPA, and this interaction may be important for regulating the onset of the S-phase (24) .
In the present work, we demonstrate an interaction between human UDG from the UNG gene (UNG) and RPA using the two-hybrid system in yeast, enzyme-linked immunosorbent assay (ELISA), and a UDG activity assay. The results show that RPA2, but neither the homolog RPA4 nor RPA1, binds to UNG. This interaction is dependent on the N-terminal presequence in UNG. The presequence, which is not necessary for the catalytic activity of UNG, contains a region of 23 amino acids with strong homology to the conserved RPA2-binding region of XPA. These results indicate a possible function for RPA in base excision repair.
EXPERIMENTAL PROCEDURES
Two-hybrid Assay-Yeast reporter strain HF7c, used in the twohybrid system, contains two Gal4-inducible reporter genes, HIS3 and LacZ (MATCHMAKER Two-hybrid system, Clontech Laboratories Inc.). Plasmid vectors, pGBT9 and pGADGH, encoding the Gal4 DNAbinding domain, Gal4-BD, (Gal4 residues 1-147) and Gal4-activating domain, Gal4-AD (Gal4 residues 768 -881), respectively, were used to express hybrid proteins. pGBT9 and pGADGH also contain the yeast Trp1 and the Leu2 genes, respectively, as selectable markers. To screen for protein interactions in the two-hybrid system, we used pGB-TUNG⌬28, constructed by insertion of UNG⌬28-cDNA, which lacks the 28 N-terminal amino acids of the open reading frame, into EcoRI/SalIdigested pGBT9, and a Jurkat cell cDNA library, constructed in fusion with Gal4-AD in pGAD1318. The yeast reporter strain HF7c was sequentially cotransformed with the UNG⌬28 hybrid expression plasmid and the Jurkat cell cDNA library (100 g) according to Bartel and Fields (25) . Interactions with the UNG⌬28 hybrid protein were assayed as described by Clontech Laboratories Inc. Positive clones were further tested for specificity by retransformation into HF7c either with pGB-TUNG⌬28 or with extraneous targets as yeast pGBTSNF1 or pGBT9. The SNF1-Gal4-BD/SNF4-Gal4-AD interaction in the two-hybrid system was used as positive control (26) , and plasmid vectors without insert were used as negative control. The cDNA inserts from positive clones were sequenced using primer walking and TaqPRISM™ Ready Reaction DyeDeoxy™ terminator cycle sequencing kit on an Applied Biosystems model 373A DNA sequencing system (Applied Biosystems). The human RPA2 hybrid with the Gal4-AD in pGADGH (isolated from a HeLa cDNA library, Clontech Laboratories Inc.) was kindly supplied by K. Tanaka (27) . In order to identify amino acids involved in the interaction between UNG and human RPA2 (p34), pGBTUNG⌬75 and pGBTUNG⌬84 were constructed the same way as pGBTUNG⌬28. Sequencing of the vectors were performed in order to ensure in frame reading. Yeast cells were cotransformed with pGAD-RPA2 and pGBT-UNG⌬28 or pGBT-UNG⌬75, and necessary controls were performed. The filter assay was performed according to Clontech Laboratories Inc. pACTRPA1 was constructed by cloning the RPA1 NcoI-SalI fragment from pRPA70 into the NcoI-XhoI sites of pACT2 (28) . pACTRPA2 was constructed by cloning the RPA2 XhoI-EcoRI fragment from pJGRPA2 into the XhoI-EcoRI sites of pACT2. pACTRPA4 was constructed by cloning a PCR-generated fragment encoding the open reading frame of RPA4 into the BamHI site of pACT11. UNG⌬28 was fused to the Gal4 DNA-binding domain in the pAS vector and called pASIUNG⌬28. The ␤-galactosidase assay was performed as described by Harper et al. (28) ) instead of dTTP. PCR products were purified by gel filtration followed by adsorption to glass milk and subsequent elution according to the Geneclean II protocol (BIO 101, Inc., Vista, CA) in order to remove excess primers and free nucleotides. [ 3 H]Uracil-containing DNA (60,000 dpm/l and ϳ 1 ng of DNA/l) was stored in 1 ϫ TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA) at Ϫ80°C.
Purification of UNG⌬28 and UNG⌬84 -Heterologous expression and purification of UNG⌬84 (lacking 84 amino acids of the N-terminal part) have been described previously (5) . UNG⌬28 (lacking the Nterminal 28 amino acids in the presequence) was expressed using a Baculovirus system 2 and purified to homogeneity as described for UNG⌬84 (5) . The UDG activity of UNG⌬28 is severalfold lower than that of UNG⌬84 on the substrate used in the present experiments. 2 Purified proteins were stored in 50 mM Hepes, pH 8.0, 1 mM dithiothreitol, 0.125 M NaCl, and 50% glycerol at Ϫ20°C.
Assays for the Effect of RPA on UDG Activity on Double-and Singlestranded DNA Substrate-To test the effect of trimeric RPA on UDG activity, UNG⌬28 or UNG⌬84 (10 ng) and recombinant trimeric RPA (200 ng), kindly provided by Dr. M. S. Wold (29) , were incubated for 30 min on ice in 200 l of 2 mM NaCl, 40 mM Tris acetate, pH 7.0, 1.6 mM MgCl 2 , 0.2 mg/ml bovine serum albumin, and 0.2 mM dithiothreitol. Then aliquots of the preincubation mixture were diluted in the same buffer to equal enzyme activities, mixed with double-stranded [ 3 H]uracil-containing DNA prepared by PCR, and UDG activity measured as described (30) .
To investigate whether RPA bound to single-stranded DNA could recruit UNG to DNA, 100 ng of RPA diluted in assay buffer was preincubated on ice for 30 min with rate-limiting amounts of heatdenatured [
3 H]uracil-containing single-stranded DNA prepared by nick translation of calf thymus DNA (30) . This was done by diluting the assay volume to 200 l such that the final concentration of [ 3 H]uracil (in DNA) was approximately 0.27 M, which is severalfold below K m for both forms of UNG. Then 40 pg of UNG⌬84 or 3.5 ng of UNG⌬28 were added, and the assay was mixture incubated at 37°C for time periods specified in the results. UDG activity was determined as described in Ref. 30 . To investigate whether RPA in solution could recruit UNG to DNA, UNG proteins and RPA were preincubated and then substrate was added under otherwise similar conditions.
Sandwich ELISA for UNG Binding to RPA-Wells of immunoplates (Nunc Maxisorb, Roskilde, Denmark) were coated with 1 g of RPA in 100 l of phosphate-buffered saline (PBS), pH 7.4, at 4°C overnight. All subsequent incubations were done at room temperature. The wells were blocked by incubation with 1 mg of bovine serum albumin in 200 l of PBS for 1 h and washed with PBS (three times with 200 l/well). Then varying concentrations of UNG⌬28 or UNG⌬84 in 100 l of PBS with 2% fetal calf serum were added to the wells, and the plates incubated for 1 h. After washing as above, protein A-purified rabbit antibodies raised against UNG⌬84 (5) were added (15 ng/well). The anti-UNG antibodies (PU101) detect UNG⌬28 and UNG⌬84 equally well in an ELISA system when they are coated directly onto immunoplates. 2 After further incubation for 1 h and subsequent washing with PBS, horseradish peroxidase-conjugated swine anti-rabbit IgG (Dacopatts A/S, Glostrup, Denmark) was added and binding quantitated using a colorimetric method (o-phenylenediamine, Dacopatts A/S) according to the manufacturer's instructions.
Digestion of UNG with Proteinase K-UNG proteins were treated with proteinase K, separated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), blotted, and visualized as follows: 3.2 pmol of UNG⌬28 (calculated molecular mass 30.9 kDa, SDS-PAGE molecular mass 33 kDA) or UNG⌬84 (calculated molecular mass 25.5 kDa, SDS-PAGE molecular mass 27 kDa) diluted in UDG buffer (10 mM NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 1 mM dithiothreitol, and 0.5 mg/ml bovine serum albumin) were incubated with 400 ng of proteinase K (Sigma) in a total volume of 100 l for 0 and 160 min at room temperature. At 160 min 100 l of UDG buffer or UDG buffer containing 1 mM phenylmethylsulfonyl fluoride (Sigma) were added to the tubes which were immediately placed on ice. To test whether RPA protected UNG⌬28 against protease digestion, 3.2 pmol of UNG⌬28 diluted in UDG buffer were preincubated on ice with 8.6 pmol (1 g) RPA in a total volume of 100 l for 30 min. Then the sample was split in two equal parts, incubated with 400 ng of proteinase K or buffer for 160 min at room temperature, and digested UNG proteins analyzed by Western blotting using PU101 antibodies for detection (5) .
RESULTS

Interaction between UNG and RPA2 (p34) in the Two-hybrid
System-Using the hybrid protein Gal4-BD-UNG⌬28, a human Jurkat cDNA library fused to Gal4-AD in pGAD1318 (gift from J. Camonis, U248, INSERM, Paris) was screened in the yeast two-hybrid system with a transformation efficiency of 2.5 ϫ 10 6 transformants/100 g of library DNA used. From a 5.6-fold amplification, 62 positive clones were identified. All these clones indicated an interaction between UNG⌬28 and a protein closely related to RPA2 as determined by nucleotide sequencing. Initially we assumed that this was a new homolog of RPA2. However, this potential RPA2 homolog hybridized strongly to genomic DNA from rat and not to human DNA. Furthermore, the nucleotide sequence of this cDNA clone was identical to a partial cDNA clone for rat RPA2 given the accession number H32647 in GenBank™. Therefore this new RPA2 cDNA clone most probably results from contamination of the human cDNA library with cDNA from rat and has consequently been reported to GenBank™ (accession number X98490) as a putative rat homolog of human RPA2 showing 89% identity with the human protein. Using this information, interaction between the human hybrid proteins Gal4-BD-UNG⌬28 and Gal4-AD-RPA2 (authentic human RPA2) was demonstrated with both His3 and LacZ reporter genes (Fig. 1, panel A) . No interaction was detected between the Gal4-AD-RPA2 and Gal4-BD-UNG⌬75 (Fig. 1, panel B) or Gal4-BD-UNG⌬84 hybrid proteins (data not shown), indicating that the binding of RPA2 to UNG is dependent on the presequence of UNG. This interaction between RPA2 and UNG is specific, since the RPA2 hybrid did not interact with other irrelevant Gal4-BD hybrid proteins such as Gal4-BD-SNF1 or the unfused Gal4BD (Fig. 1A) . In addition to the controls specified in Fig. 1, panels A and B, we tested for interaction between Gal4-BD-UNG⌬28 and Gal4-AD or Gal4-AD-SNF4, but no such unspecific binding was observed (data not shown).
Although no other interactions were observed after screening with the cDNA library, we investigated the possible interaction of UNG⌬28 with RPA1 (known to interact with XPA) and RPA4 using a modified version of the two-hybrid system (28) . Human RPA1, RPA4, and RPA2 (as a positive control) were each fused to the Gal4-AD in the pACT vector, and UNG⌬28 was fused to the Gal4-BD in the pAS vector. As shown in Fig. 1C, UNG⌬28 interacted only with RPA2 and not with RPA1 or RPA4. We did not directly test for possible interaction with RPA3, but such an interaction may not be likely since it could not be demonstrated when human UNG was screened against the Jurkat T-cell cDNA library.
The C-terminal Region of RPA2 Interacts with UNG-The longest and shortest RPA2-cDNA clones obtained from the screening, started at positions corresponding to amino acids 4 and 136 in human RPA2, indicating that the C-terminal region of RPA2 from amino acid residue 136 -271 is sufficient for binding to UNG. UNG probably interacts with an amino acid region of RPA2 that is divergent in RPA4. Although RPA4 has a 47% overall identity with RPA2, a region located between positions 184 and 210 in RPA2 is distinctly different in the corresponding region in RPA4. Alignment of human RPA2 with RPA2 from other species shows that this region appears to be conserved in mammals, but not in lower eukaryotes or the human RPA2 homolog RPA4 (Fig. 2) .
Binding of Trimeric RPA to UNG in Vitro and Effect on UDG Activity of UNG Proteins-To examine whether physiologically active trimeric form of RPA interacted with UNG in vitro, ELISA assays using UNG-Ab and purified recombinant trimeric RPA together with purified UNG⌬28 or UNG⌬84 were performed. Data shown in Table I support the UNG⌬28-RPA interaction, while the severalfold lower absorbance detected with UNG⌬84 may represent unspecific interaction close to the detection limit or very weak specific interactions. This experiment demonstrated that the RPA2-UNG interaction is direct and does not require a yeast intermediate protein.
Furthermore, UNG binds to RPA2 in its heterotrimeric physiological context.
We also tested the effect of trimeric RPA on UDG activity of UNG proteins on double-stranded DNA substrate. Since RPA binds strongly to single-stranded DNA, a UDG substrate without detectable gaps or single-stranded regions (generated by PCR) was used for this purpose. Using this substrate in the presence of excess trimeric RPA, UDG activity of UNG⌬28 was inhibited by approximately 25%, while the UDG activity of UNG⌬84 remained unaffected (Table II) . These in vitro assays support the view that the interaction between the two proteins is specific and not an artifact observed with the hybrid protein in the two-hybrid system. Furthermore, the lack of effect of RPA on UNG⌬84, which does not contain the presequence, is FIG. 1. Specific interaction of UNG with human RPA in the two-hybrid system. The reporter strain HF7c transformed with pGADp34 and pGBTUNG⌬28 (panel A) or pGBTUNG⌬75 (panel B) was analyzed for histidine auxotrophy and ␤-galactosidase activity. Transformants were plated on medium with histidine, but without tryptophan and leucine (Hisϩ), replica-plated on medium without tryptophan, leucine, and histidine (HisϪ), and on Whatman 40 filter on Hisϩ medium in order to test for ␤-galactosidase activity. Growth in the absence of histidine and blue colonies in the ␤-galactosidase test indicate interaction between hybrid proteins. Interaction between SNF1 and SNF4 yeast proteins was used as a positive control. The interaction between UNG⌬28 and RPA2 was also verified in a modified two-hybrid system (28), while no interaction between UNG⌬28 and RPA1 or RPA4 was detected (panel C).
FIG. 2. Alignment of the possible UNG-binding region (position 184 -210) at the C-terminal part of human RPA2 (accession number J05249) (first line) and corresponding regions in RPA2
from rat (accession number X98490) (second line), mouse (accession number D00812) (third line), S. cerevisiae (P22138) (fourth line), Crithidia fasciculata (accession number Z23164) (fifth line), and human RPA4 (accession number U24186) (sixth line).
TABLE I
Binding of UNG to trimeric RPA detected by ELISA Wells of microtiter plates were coated with RPA, exposed to UNG⌬28 or UNG⌬84, and developed as described under "Experimental Procedures." In order to investigate whether the strong DNA binding capacity of RPA could mediate recruitment of UNG to singlestranded DNA, UDG assays were performed under conditions where the concentration of single-stranded DNA substrate was limiting. Neither preincubation of trimeric RPA with substrate nor preincubation of trimeric RPA with UNG⌬28 or UNG⌬84 resulted in consistently increased UDG activity. Rather, a weak inhibition of UDG activity was mostly observed under the varying conditions used; thus we could not demonstrate significant recruitment of UNG by RPA in these in vitro experiments (Table III) .
The RPA2-binding Region in UNG Is Homologous to the RPA2-binding Region in XPA-
The region of XPA required for interaction with RPA2 is located within the N-terminal 58 amino acid residues (16) . Interestingly, within the 49 amino acids of the presequence of UNG, which interacts with RPA2, a 23-amino acid region with strong homology to the RPA2-binding region of XPA is found. The hydrophobicity/hydrophilicity profiles are also very similar. When allowing for two gaps of 2 amino acids, 11 out of 23 amino acids are identical (47.8% identity), and in addition 3 are conserved (60.9% similarity), (Fig. 3, panel A) . XPA from several other species also show homology to this region of human UNG with chicken showing the highest homology (60.9% identity and 78.3% similarity). SV40 T-antigen, which also binds to the C-terminal region of RPA2 (19) , has a 26-amino acid region with limited homology to human UNG. In addition, a protein in the cyclin family (UNG2) apparently having UDG activity also has a region of homology to UNG and XPA (Fig. 3B) . The presequence of mouse UDG 3 is also strongly homologous to human UDG and contains the putative RPA2-binding motif. The corresponding region is also conserved in UDG from the fish Xiphophorus, although more distantly related, 4 but is absent in UDG from yeast or animal viruses (various herpes simplex viruses and pox viruses) (data not shown). Although limited to a small region, this is, to our knowledge, the first homology demonstrated between damage recognizing proteins in the nucleotide excision repair and base excision repair pathways.
In conclusion, these results support the biochemical data and suggest that residues 57-79 in human UNG and 20 -46 in XPA interact with RPA2.
The RPA2-binding Presequence in UNG Probably Constitutes a Separate Structural Domain-The crystal structure of UNG⌬84, a catalytically fully active enzyme, has revealed a globular one-domain protein with the N-terminal region localized on the surface. Using proteinase K digestion, the presequence is easily removed from UNG⌬28, resulting in a processed form slightly longer than UNG⌬84 (Fig. 4, lanes 2 and  3) . No further digestion of UNG⌬28 is observed. Purified UNG⌬84 is proteinase K-resistant, probably due to its compact structure (lanes 2 and 4) . In an attempt to examine whether binding of RPA to UNG⌬28 affected the proteinase K digestion, UNG⌬28 was preincubated with RPA and then incubated with proteinase K. Lanes 2 and 6 show that RPA did not protect UNG⌬28 from protease digestion. Proteinase K treatment of UNG⌬28 removed the presequence without any loss of activity, in fact the activity is increased (data not shown), whereas the catalytic activity of UNG⌬84 was not affected by the proteinase K treatment. The shorter form of UNG resulting from proteinase K treatment could not have resulted from digestion at the C-terminal end, because deletion of only the last 4 amino acids at the C-terminal end by site-directed mutagenesis where Trp-301 was converted to a stop codon resulted in complete loss of activity (data not shown). These results, together with the results obtained in the two-hybrid studies, indicate that the presequence constitutes a separate structural domain required for RPA binding, but not for catalytic activity.
DISCUSSION
In this report we demonstrate an interaction between human UNG and human RPA in vivo, using the yeast two-hybrid system, and in vitro by an ELISA assay using purified trimeric RPA and purified forms of human UDG (UNG⌬28 or UNG⌬84). Only the 34-kDa subunit of RPA2 interacts directly with UNG, and the interaction results in a weak inhibitory effect on UDG activity rather than stimulation. The weak inhibitory effect may be an in vitro effect, and we do not suggest that RPA inhibits UDG activity in the much more complex in vivo situation; this result merely strengthens the other results showing that the presequence is involved in an interaction between UNG and RPA, since a possible functional consequence on UDG activity should be confirmed inside cells. Previously, RPA has been shown to be involved in the damage recognition step of nucleotide excision repair (14) , in recombination repair (15) , and in replication (13) , but a possible involvement in base excision repair has not been reported, except for a possible role of RPA as a transcription factor in the regulation of expression of DNA repair genes (11) . A putative element for binding of RPA is located in an inhibitory region of the UNG promoter (9, 10) . In nucleotide excision repair, XPA interacts with both RPA2 and RPA1, but whereas RPA1 is essential for cell survival after UV light exposure, RPA2 has a more modest although significant effect (16) . A region between amino acids 28 and 78 in UNG is necessary for interaction with RPA2, but we have not formally shown that this region is sufficient for interaction. Interestingly, amino acids 57-79 in UNG show strong homology to amino acids 20 -46 in human XPA. Since XPA residues 1-59 are necessary and 1-74 sufficient for binding to RPA2 (16) , it seems likely that the region of homology between amino acids 57-79 in human UNG and amino acids 20 -46 in XPA are the actual RPA2-binding regions. At the C-terminal end of the region of homology, the amino acid sequence RLAAR is present in both UNG and XPA. However, this sequence does not appear to be sufficient for RPA2 binding, since Gal4-BD-UNG⌬75 that starts with this sequence did not interact in the two-hybrid system. Our results indicate that the interacting region in human RPA2 is located downstream of the first 136 amino acid residues. A conserved region in RPA2 from mammals, lacking in RPA4 and RPA2 from lower eukaryotes, is present between residues 184 and 210. This may be a candidate region for binding of UNG, and if so, the pattern of conservation would indicate that only RPA from higher eukaryotes will recognize UNG, analogous to the ability of RPA from mammals, and inability of RPA from lower eukaryotes like Saccharomyces cerevisiae to bind to T-antigen and to stimulate SV40 replication (17, 18) .
One possible function of RPA2 could be to recruit UNG to a DNA repair complex possibly associated with the replication complex for scanning for uracil prior to replication. A related function has been proposed for SV40 T-antigen which, like dnaC, P protein, and the T4 phage gp59 protein, facilitate primase recognition of RPA-coated DNA (Ref. 18 and references therein). Alternatively, RPA2 might assist transport of UNG either to the nucleus or within the nucleus. Among the three subunits, only RPA2 is associated with the nuclear matrix and this association persists throughout the cell cycle (31) . In addition, RPA2 and RPA1 undergo a transition from uniform nuclear distribution to the punctuate nuclear pattern typical for replication foci during the S-phase (32) . Nuclear staining of UNG also displays a nonhomogeneous distribution reminiscent of replication foci (33) , although it has not been shown that UNG and replication foci colocalize. One of the functions of RPA2 could be to contribute to the localization of UNG in replication foci. UDG activity is not essential for DNA replication in E. coli or S. cerevisiae (34, 35) . In contrast, it is essential for poxvirus replication (36) and for the replication of a herpes virus (HSV1) in mammalian cells that do not express cellular UDG (37) . In human cells, UNG is most actively transcribed very late in the G 1 -phase and UDG activity subsequently increases 2-3-fold early in the S-phase (8) . In addition, an association of UDG activity with replicating SV40 minichromosomes (7) may indicate a possible function for UNG in replication or in an associated repair complex.
The protease digestion in the present study indicates that the first approximately 80 amino acids, comprising the presequence of UNG, constitute a second structural domain separated from the previously reported structure of the catalytic domain by at least one protease-accessible site (6) . We have reported previously that the nuclear and mitochondrial form of human UDG have a size corresponding to the "mature" form lacking the presequence of 77 amino acids, while a larger form that reacted with an antibody specific for the presequence was present in the cytosol fraction. In addition, transfection experiments indicated that the presequence was essential for mitochondrial import, but not for nuclear import (38) . However, there are some inconsistencies in the literature regarding the size of nuclear UDG, since some reports indicate a size consistent with processing of the N-teminal end (39, 40) , whereas others report a size essentially corresponding to the larger "preform" (41, 42) . In conclusion, we do not yet know whether processing at the N-terminal end is a physiological process or merely an in vitro artifact during purification. Proteolytic cleavage of UDG during purification has been reported in yeast (43) , and a similar digestion of human nuclear UNG may take place. However, the interaction of the "presequence" of UNG with RPA, a truly pleiotropic nuclear protein, necessitates further studies on the biochemistry of nuclear uracil-DNA glycosylase and possible accessory proteins assisting in base excision repair.
